Combination Treatment for Augmenting Language in Children With ASD

Completed · Phase 2 · Has a placebo group

Conditions studied: Autism Spectrum Disorder

In brief

The study will consist of two main elements: the enrollment of 72 children aged 6-11 years with ASD and low language competency to receive a thrice-weekly one hour language intervention for 12 weeks; and, beginning at the same time, subjects will be equally randomized to receive either aripiprazole (Abilify) (flexibly dosed from 2-10 mg per day) or placebo for 12 weeks.

Key facts

Study ID
NCT02574741
Run by
University of California, Los Angeles
People needed
58
Starts
2012-06-01
Expected to finish
2019-12-01
Last updated by the study team
2020-04-29

Who can join

Age: 5 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.